HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53
Didier Meulendijks(AstraZeneca (Brazil)), Annemieke Cats(Oncode Institute)
Cited by 113
Related Papers
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis
|The Lancet Oncology|2018|419
White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
|Nature Communications|2020|238
Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy
|Cancer Chemotherapy and Pharmacology|2015|55